Physician profile
Ravi Medi
NPI 1386621977
$13,720.37
in general payments reported to CMS, 2019-2025
17 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $372 · 2021: $11K · 2022: $644 · 2023: $319 · 2024: $306 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $915.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $10,339.39 | 2021-2022 | |
| Abbvie INC. | $806.59 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $635.53 | 2019-2024 | Trintellix |
| Alkermes, INC. | $342.75 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $337.19 | 2020-2025 | Ingrezza |
| Allergan, INC. | $305.68 | 2019-2020 | |
| Lundbeck LLC | $233.74 | 2019-2024 | Rexulti |
| Corium, LLC | $205.15 | 2021-2023 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $105.22 | 2022 | |
| Eisai INC. | $91.33 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $80.25 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $69.24 | 2019 | |
| Shire North American Group INC | $41.84 | 2019 | |
| Ironshore Pharmaceuticals INC. | $40.65 | 2019-2023 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $37.51 | 2019-2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $28.18 | 2019 | |
| Idorsia Pharmaceuticals US INC | $20.13 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Medi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.